Physician profile
Michael D Addis
NPI 1275525743
$15,799.62
in general payments reported to CMS, 2019-2025
35 companies · $1,801 in 2025
The $1,801 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,845 · 2020: $720 · 2021: $1,754 · 2022: $3,572 · 2023: $2,104 · 2024: $3,003 · 2025: $1,801.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,908.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,908.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,985.45 | 2021-2025 | Hawkone, Endurant Iis, Spiderfx |
| Silk Road Medical, INC. | $2,130.23 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| W. L. Gore & Associates, INC. | $1,859.58 | 2021-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Viabahn Vbx Balloon Expandable Endo, Gore Tag Conformable Thoracic Endoprosthesis |
| Inari Medical, INC. | $1,377.52 | 2019-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Penumbra, INC. | $1,321.11 | 2019-2025 | Indigo System, Ruby Coil |
| Endologix LLC | $1,121.68 | 2019-2024 | Alto Abdominal Stent Graft System |
| Bolton Medical INC | $633.80 | 2022-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| Cardiovascular Systems INC. | $431.63 | 2019-2022 | |
| Tactile Systems Technology INC | $409.28 | 2020-2024 | Entre Plus, Flexitouch Plus |
| Medtronic Vascular, INC. | $375.40 | 2019-2020 | |
| Boston Scientific Corporation | $368.05 | 2025 | Watchman Flx, General - Non-Vascular Intervention, General - Angioplasty |
| Abbott Laboratories | $316.66 | 2019 | |
| Convatec INC. | $287.29 | 2023-2024 | |
| Cook Medical LLC | $284.47 | 2022-2025 | Zenith Alpha |
| Bard Peripheral Vascular, INC. | $268.38 | 2020-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $241.97 | 2025 | Restrata Wound Matrix |
| Smith+Nephew, INC. | $231.17 | 2019-2021 | |
| Angiodynamics, INC. | $206.60 | 2024 | Auryon Laser System 100-120 Vac |
| Sanara Medtech INC. | $150.00 | 2025 | Celleraterx |
| Lemaitre Vascular, INC. | $128.98 | 2022-2025 | Restoreflow, Artegraft Vascular Graft |
| Dilon Technologies, INC. | $113.14 | 2025 | Hemoblast Bellows |
| Ekos Corporation | $106.74 | 2019 | |
| Kerecis Limited | $80.36 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Venturemed Group, INC. | $69.59 | 2025 | Flex Vessel Prep System |
| Stryker Corporation | $54.78 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Pharmaceuticals, INC | $38.06 | 2019-2021 | |
| Terumo Medical Corporation | $35.34 | 2022 | |
| Cardiva Medical, INC. | $32.69 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Pfizer INC. | $28.04 | 2020 | |
| Organogenesis INC. | $25.71 | 2025 | Apligraf |
| Ethicon US, LLC | $23.66 | 2024 | Prolene |
| Solventum Corporation | $17.65 | 2025 | Prevena, V.A.C.Ulta |
| Kci USA, INC. | $15.55 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $15.00 | 2020 | |
| Merck Sharp & Dohme LLC | $14.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Addis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.